RayzeBio (RYZB) Institutional Ownership → He cracked the code to crypto… (From Weiss Ratings) (Ad) Free RYZB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Institutional Ownership Changes (13F Filings) for RayzeBio (NASDAQ:RYZB)Number ofInstitutional Buyers(last 12 months)39TotalInstitutional Inflows(last 12 months)$577.11MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$165.50M Get RYZB Insider Trade Alerts Want to know when executives and insiders are buying or selling RayzeBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RYZB Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingTrump’s Former Wingman Bets Big on AIOne of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here. RayzeBio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/5/2024Wellington Management Group LLP3,504,409$215.91M0.0%-9.6%5.848% 2/26/2024Perceptive Advisors LLC744,056$46.26M1.0%-4.2%1.242% 2/15/2024Blackstone Inc.108,090$6.72M0.0%+8.1%0.180% 2/14/2024Hhlr Advisors LTD.1,062,383$66.05M1.3%-23.9%1.773% 2/14/2024Commodore Capital LP383,638$23.85M2.1%+32.8%0.640% 2/14/2024PenderFund Capital Management Ltd.1,800$112K0.0%N/A0.003% Get the Latest News and Ratings for RYZB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RayzeBio and its competitors with MarketBeat's FREE daily newsletter. 2/14/2024Harvest Management LLC50,000$3.11M2.9%N/A0.083% 2/14/2024Water Island Capital LLC225,565$14.02M1.4%N/A0.376% 2/13/2024GABELLI & Co INVESTMENT ADVISERS INC.38,850$2.42M0.5%N/A0.065% 2/13/2024Gabelli Funds LLC52,600$3.27M0.0%N/A0.088% 2/13/2024Tower Research Capital LLC TRC 826$51K0.0%+403.7%0.001% 2/13/2024Capital Research Global Investors170,808$10.62M0.0%-86.3%0.285% 2/9/2024 Franklin Resources Inc.511,401$31.79M0.0%-38.6%0.853% 2/7/2024 Versor Investments LP80,771$5.02M1.0%N/A0.135% 2/7/2024 Alpine Associates Management Inc.762,900$47.43M2.4%N/A1.273% 2/7/2024Kellner Capital LLC12,200$758K1.4%N/A0.020% 2/7/2024 Vivo Capital LLC110,581$6.88M0.6%-82.5%0.185% 2/6/2024 Charles Schwab Investment Management Inc.147,140$9.15M0.0%N/A0.246% 2/6/2024 BCK Capital Management LP15,000$933K0.9%N/A0.025% 2/6/2024 M&T Bank Corp7,480$466K0.0%N/A0.012% 2/6/2024 Amalgamated Bank2,347$146K0.0%N/A0.004% 2/5/2024 Victory Capital Management Inc.4,055$252K0.0%N/A0.007% 2/1/2024 Wolverine Asset Management LLC11,700$727K0.0%N/A0.020% 2/1/2024 New York State Common Retirement Fund8,969$558K0.0%+796.9%0.015% 1/30/2024 Strs Ohio4,300$267K0.0%N/A0.007% 1/12/2024 SG Americas Securities LLC8,138$506K0.0%N/A0.014% 12/13/2023Teachers Retirement System of The State of Kentucky19,131$425K0.0%N/A0.032% 12/6/2023 Citigroup Inc.24,907$553K0.0%N/A0.042% 12/1/2023Wellington Management Group LLP3,876,186$84.49M0.0%N/A6.469% 11/15/2023RTW Investments LP46,300$1.03M0.0%N/A0.080% 11/15/2023Redmile Group LLC1,857,706$41.24M2.0%N/A3.192% 11/15/2023Laurion Capital Management LP971,913$21.58M0.1%N/A1.670% 11/15/2023Acuta Capital Partners LLC344,571$7.65M5.1%N/A0.592% 11/14/2023venBio Partners LLC5,158,162$114.51M32.5%N/A8.864% 11/14/2023Braidwell LP277,778$6.17M0.2%N/A0.477% 11/14/2023Blackstone Inc.100,000$2.22M0.0%N/A0.172% 11/14/2023Soros Fund Management LLC20,000$444K0.0%N/A0.034% 11/14/2023Deerfield Management Company L.P. Series C1,159,126$25.73M0.6%N/A1.992% 11/14/2023Avidity Partners Management LP500,000$11.10M0.4%N/A0.859% 11/14/2023Monashee Investment Management LLC27,500$610K0.3%N/A0.047% Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here.11/13/2023 FMR LLC1,138,972$25.29M0.0%N/A1.957% 11/13/2023Maven Securities LTD59,835$1.33M0.0%N/A0.103% 11/9/2023 Citigroup Inc.24,907$553K0.0%N/A0.043% 11/8/2023 Vivo Capital LLC633,576$14.07M1.7%N/A1.089% 11/3/2023 Versant Venture Management LLC5,158,161$114.51M61.0%N/A8.864% 11/3/2023 Platinum Investment Management Ltd.222,222$4.93M0.2%N/A0.382% 10/27/2023 TD Asset Management Inc72,610$1.61M0.0%N/A0.125% (Data available from 1/1/2016 forward) RYZB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RYZB shares? During the previous two years, 43 institutional investors and hedge funds held shares of RayzeBio. The most heavily invested institutionals were Wellington Management Group LLP ($215.91M), venBio Partners LLC ($114.51M), Versant Venture Management LLC ($114.51M), Hhlr Advisors LTD. ($66.05M), Alpine Associates Management Inc. ($47.43M), Perceptive Advisors LLC ($46.26M), and Redmile Group LLC ($41.24M).Learn more on RYZB's institutional investors. Which institutional investors have been buying RayzeBio stock? Of the 39 institutional investors that purchased RayzeBio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: venBio Partners LLC ($5.16M), Versant Venture Management LLC ($5.16M), Wellington Management Group LLP ($3.88M), Redmile Group LLC ($1.86M), Deerfield Management Company L.P. Series C ($1.16M), FMR LLC ($1.14M), and Laurion Capital Management LP ($971.91K). How much institutional buying is happening at RayzeBio? Institutional investors have bought a total of 23,229,857 shares in the last 24 months. This purchase volume represents approximately $577.11M in transactions. Which RayzeBio major shareholders have been selling company stock? The following institutional investors have sold RayzeBio stock in the last 24 months: Capital Research Global Investors ($1.08M), Vivo Capital LLC ($523.00K), Wellington Management Group LLP ($371.78K), Hhlr Advisors LTD. ($333.33K), Franklin Resources Inc. ($321.93K), and Perceptive Advisors LLC ($32.75K). How much institutional selling is happening at RayzeBio? Institutional investors have sold a total of 2,661,978 shares in the last 24 months. This volume of shares sold represents approximately $165.50M in transactions. Related Companies: Iovance Biotherapeutics Major Shareholders Integer Major Shareholders Biohaven Major Shareholders HUTCHMED Major Shareholders Crinetics Pharmaceuticals Major Shareholders Insmed Major Shareholders RadNet Major Shareholders Axsome Therapeutics Major Shareholders Prestige Consumer Healthcare Major Shareholders Surgery Partners Major Shareholders This page (NASDAQ:RYZB) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RayzeBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.